본문으로 건너뛰기
← 뒤로

Long-Term Health and Economic Impacts of COVID-19 Disruptions on Bowel Cancer Inequalities in Victoria, Australia: A Modelling Study.

Cancer medicine 2026 Vol.15(4) p. e71816

Lal A, Mudford E, Merga BT, Gao L, Sinclair C, Broun K, Yeung JM, McCaffrey N

📝 환자 설명용 한 줄

[INTRODUCTION] The COVID-19 pandemic significantly disrupted colorectal cancer (CRC) diagnosis and treatment globally.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Lal A, Mudford E, et al. (2026). Long-Term Health and Economic Impacts of COVID-19 Disruptions on Bowel Cancer Inequalities in Victoria, Australia: A Modelling Study.. Cancer medicine, 15(4), e71816. https://doi.org/10.1002/cam4.71816
MLA Lal A, et al.. "Long-Term Health and Economic Impacts of COVID-19 Disruptions on Bowel Cancer Inequalities in Victoria, Australia: A Modelling Study.." Cancer medicine, vol. 15, no. 4, 2026, pp. e71816.
PMID 41992350
DOI 10.1002/cam4.71816

Abstract

[INTRODUCTION] The COVID-19 pandemic significantly disrupted colorectal cancer (CRC) diagnosis and treatment globally. Most research on long-term impacts has focused on population-level outcomes, overlooking disparities in under-screened groups. This study examines the long-term effects of COVID-19 disruptions on health inequalities and healthcare costs in Victoria, Australia.

[METHODS] A Markov microsimulation model (PRISM-CRC), containing socioeconomic quintiles in Victoria, estimated health outcomes in a population aged 50-74 years from 2023-2037. The model simulated the development of CRC, considering the expected population increase in CRC cases projected by the Victorian Cancer Registry (VCR) due to COVID-19 disruptions and counterfactual scenarios with no disruptions. The model estimated CRC case numbers, CRC deaths, and total costs of CRC screening and treatment by quintile. Screened status, stage of diagnosis, and survival were obtained using a dataset linked to patients diagnosed with CRC in 2009-2021 from the VCR.

[RESULTS] Post COVID-19, CRC cases and mortality increased across all quintiles, with the greatest impacts in the most disadvantaged groups. Quintile 2 showed the largest relative cancer cases increase (21.7%), followed by quintile 1 (16.3%), whilst quintile 5 increased only 1.2%. CRC deaths rose 30.1% in quintile 1 and 28% in quintile 2, compared to 1.6% in quintile 5. Combined screening, diagnostic testing and treatment costs increased 21.4% in quintiles 1 and 24.8% in quintiles 2, versus 3.4% in quintile 5. Overall, the post-COVID-19 period intensifies the social gradient in CRC incidence, mortality, and healthcare costs.

[CONCLUSION] Our study underscores the significant impact of COVID-19 disruptions on worsening cancer inequalities. Targeted CRC screening interventions are essential to protect vulnerable populations. Enhanced demographic data from screening programs will help better understand non-participants and groups with low participation rates.

MeSH Terms

Humans; COVID-19; Middle Aged; Colorectal Neoplasms; Aged; Victoria; Male; Female; SARS-CoV-2; Markov Chains; Early Detection of Cancer; Healthcare Disparities; Socioeconomic Factors; Health Status Disparities; Health Care Costs; Pandemics

같은 제1저자의 인용 많은 논문 (1)